Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.2K
Tumor Progression02:07

Tumor Progression

7.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phylogenetic tree inference from single-cell RNA sequencing data with SCITE-RNA.

Genome biology·2026
Same author

Wastewater-based sequencing of respiratory syncytial virus to investigate lineage dynamics and antigenic site mutations: a retrospective genomic epidemiology study.

The Lancet. Microbe·2026
Same author

Learning and forecasting selection dynamics of SARS-CoV-2 variants from wastewater sequencing data using Covvfit.

Water research·2026
Same author

Care demand networks in maternity care - an innovative approach exploring the complexity of care demands with routine data: Retrospective observational study.

International journal of nursing studies advances·2026
Same author

Corrigendum to "Characterizing Influenza A Virus Lineages and Clinically Relevant Mutations Through High-Coverage Wastewater Sequencing" [Water Research (2025) Article No. 124453].

Water research·2026
Same author

Unifying non-Markovian dynamics and agent heterogeneity in scalable stochastic networks.

Nature communications·2026
Same journal

Redefining first-line standards: The role of next-generation HER2-Targeted therapies in HER2-positive metastatic breast cancer.

Biochimica et biophysica acta. Reviews on cancer·2026
Same journal

Organoid-based platforms for oncolytic virus discovery and optimization: Bridging in vitro innovation and clinical translation.

Biochimica et biophysica acta. Reviews on cancer·2026
Same journal

Targeting transcriptional and post-transcriptional pathways in head and neck cancer.

Biochimica et biophysica acta. Reviews on cancer·2026
Same journal

Post-transcriptional regulation in cancer chemoresistance.

Biochimica et biophysica acta. Reviews on cancer·2026
Same journal

Ferroptosis in the tumor immune microenvironment: A double-edged sword in immunotherapy.

Biochimica et biophysica acta. Reviews on cancer·2026
Same journal

Neural-tumor crosstalk in driving tumor metabolic reprogramming.

Biochimica et biophysica acta. Reviews on cancer·2026
See all related articles

Related Experiment Video

Updated: Mar 7, 2026

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

4.0K

Advances in understanding tumour evolution through single-cell sequencing.

Jack Kuipers1, Katharina Jahn1, Niko Beerenwinkel1

  • 1Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland; Swiss Institute of Bioinformatics, Basel, Switzerland.

Biochimica Et Biophysica Acta. Reviews on Cancer
|February 15, 2017
PubMed
Summary
This summary is machine-generated.

Understanding tumor evolution through mutational heterogeneity is key for personalized cancer treatments. Advanced sequencing and computational models analyze tumor phylogeny to improve patient outcomes.

Keywords:
Cancer evolutionPhylogeneticsSingle-cell sequencingTumour heterogeneity

More Related Videos

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

1.1K
Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq
06:22

Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq

Published on: August 25, 2020

13.6K

Related Experiment Videos

Last Updated: Mar 7, 2026

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

4.0K
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

1.1K
Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq
06:22

Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq

Published on: August 25, 2020

13.6K

Area of Science:

  • Oncology
  • Computational Biology
  • Genomics

Background:

  • Tumor mutational heterogeneity complicates cancer treatment development.
  • Understanding subclonal composition and mutational history is crucial for tailored therapies.
  • Tumor evolution is driven by evolutionary processes, influencing progression and metastasis.

Purpose of the Study:

  • To review state-of-the-art methods for analyzing tumor phylogeny from bulk and single-cell sequencing data.
  • To highlight future directions in modeling tumor evolution.
  • To provide insights into identifying mutational patterns for improved cancer prognostics.

Main Methods:

  • Review of computational and sequencing-based methodologies.
  • Analysis of phylogenetics from bulk sequencing data.
  • Application of single-cell sequencing for high-resolution evolutionary analysis.

Main Results:

  • Next-generation sequencing enables detailed analysis of tumor evolutionary history and heterogeneity.
  • Novel computational frameworks are emerging to address challenges in single-cell data analysis.
  • Comparative tumor studies identify patterns crucial for predicting cancer progression and treatment response.

Conclusions:

  • Advanced computational and sequencing methods are vital for deciphering tumor evolution.
  • Accurate tumor phylogeny reconstruction can lead to more effective, individualized cancer treatments.
  • Further development in modeling frameworks will enhance our understanding of cancer heterogeneity.